Cooperating oncogenic events in murine mammary tumorigenesis: Assessment of ErbB2, mutant p53, and mouse mammary tumor virus

Experimental and Molecular Pathology

Volumn 70, Issue 3, 2001, Pages 183-193

  Zelazny, Edward ^a   Li, Baolin ^a   Anagnostopoulos, Anne Marie ^a   Coleman, Allen ^b   Perkins, Archibald S ^a  

^a YALE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b Laboratory of Population Genetics   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

MUTANT PROTEIN; ONCOPROTEIN; PROTEIN ERB B2; PROTEIN P53; PROTEIN P53 172H; UNCLASSIFIED DRUG;

ALLELE; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BREAST CARCINOGENESIS; CANCER GROWTH; CANCER MODEL; CHROMOSOME 4; COMPARATIVE GENOMIC HYBRIDIZATION; CROSSING OVER; FEMALE; GENE MUTATION; GENE OVEREXPRESSION; GENOTYPE; GROWTH REGULATION; HETEROZYGOSITY; LATENT PERIOD; LYMPHOMA; MOUSE; MOUSE MAMMARY TUMOR ONCOVIRUS; NONHUMAN; ONCOGENE NEU; PROTEIN EXPRESSION; SARCOMA;

MAMMARY TUMOR VIRUS; MOUSE MAMMARY TUMOR VIRUS; MURINAE; MUS MUSCULUS; TUMOR VIRUS;

EID: 0034964481     PISSN: 00144800     EISSN: None     Source Type: Journal    
DOI: 10.1006/exmp.2001.2357     Document Type: Article

References (43)

1. The amplification unit on chromosome 11q13 in aggressive primary human breast tumors entails the bcl-1, int-2 and hst loci
2. TP53 tumor suppressor gene: A model for investigating human mutagenesis
3. Modulation of activity of the promoter of the human MDR1 gene by Ras and p53
4. Crystal structure of a p53 tumor suppressor-DNA complex: Understanding tumorigenic mutations
5. Genetic basis for p53 overexpression in human breast cancer
6. Gain of function mutations in p53
7. Quantitative analysis of comparative genomic hybridization
8. Participation of p53 cellular tumor antigen in transformation of normal embryonic cells
9. Susceptibility of AKXD recombinant inbred mouse strains to lymphomas
10. Expression of the neu protooncogene in the mammary epithelium of transgenic mice induces metastatic disease
11. A mutant p53 transgene accelerates tumour development in heterozygous but not nullizygous p53-deficient mice
12. Mutant p53 DNA clones from human colon carcinomas cooperate with ras in transforming primary rat cells: A comparison of the "hot spot" mutant phenotypes
13. p53 mutations in human cancers
14. Mutant p53, EGF receptor and c-erbB-2 expression in human breast cancer
15. Gain-of-function mutations of the p53 gene induce lymphohematopoietic metastatic potential and tissue invasiveness
16. The biology of erbB-2/neu/HER-2 and its role in cancer
17. Tumor spectrum analysis in p53-mutant mice
18. Participation of p53 protein in the cellular response to DNA damage
19. Mutated p53 binds DNA abnormally in vitro
20. Oncogenic forms of p53 inhibit p53-regulated gene expression
21. p53: Puzzle and paradigm
22. Wild-type p53 is a cell cycle checkpoint determinant following irradiation
23. Inactivation of the retinoblastoma susceptibility gene in human breast cancers
24. Neu/ErbB2 cooperates with p53-72H during murine mammary tumorigenesis in transgenic mice
25. p53 is required for radiation-induced apoptosis in mouse thymocytes
26. Absence of p53 allows direct immortalization of hematopoietic cells by the myc and raf oncogenes
27. Cotranslation of activated mutant p53 with wild type drives the wild-type p53 protein into the mutant conformation
28. Single-step induction of mammary adenocarcinoma in transgenic mice bearing the activated c-neu oncogene
29. Mutations in the p53 gene occur in diverse human tumor types
30. Insertional mutagenesis in mouse mammary tumorigenesis
31. Evidence that p53 behaves as a tumour suppressor gene in sporatic breast tumours
32. Loss of hetorozygosity analysis in primary mammary tumors and lung metastases of MMTV-MTAg and MMTV-neu transgenic mice
33. Analysis of pp60 c-src protein kinase activity in human tumor cell lines and tissues
34. Immortalization of rat embryo fibroblasts by the cellular p53 oncogene
35. Nonrandom cytogenetic alterations in hepatocellular carcinoma from transgenic mice overexpressing c-Myc and transforming growth factor-alpha in the liver
36. Novel activating mutations in the neu proto-oncogene involved in induction of mammary tumors
37. Human breast cancer: Correlation of relapse and survival with amplification of the HER-2/Neu oncogene
38. Studies of the HER-2/neu protooncogene in human breast and ovarian cancer
39. p53-dependent apoptosis suppresses tumor growth and progression in vivo
40. A recurring pattern of chromosomal aberrations in mammary gland tumors of MMTV-cmyc transgenic mice
41. Genome wide search for genetic damage in p53 transgenic mouse lung tumours reveals consist loss of chromosome 4
42. Wildtype p53 induces apoptosis of myeloid leukemic cells that is inhibited by interleukin-6